世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

コエンザイムQ10の世界市場 2021-2025年

コエンザイムQ10の世界市場 2021-2025年


Global Coenzyme Q10 Market 2021-2025

コエンザイムQ10の世界市場 2021-2025年 Technavio社は、コエンザイムQ10市場をモニタリングしており、予測期間中に6.13%のCAGRで進行し、2021-2025年に242.36百万ドルの成長が見込まれています。当レポートでは... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
TechNavio
テクナビオ 		2021年8月17日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら 		2営業日程度 120 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

コエンザイムQ10の世界市場 2021-2025年
Technavio社は、コエンザイムQ10市場をモニタリングしており、予測期間中に6.13%のCAGRで進行し、2021-2025年に242.36百万ドルの成長が見込まれています。当レポートでは、コエンザイムQ10市場について、全体的な分析、市場規模と予測、動向、成長要因、課題のほか、約25社のベンダーを対象としたベンダー分析も行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、可処分所得の増加、高齢者人口の増加、健康的な食生活への関心の高まりなどです。また、可処分所得の増加は、市場の成長を後押しすると予想されています。
coenzyme Q10の市場分析には、アプリケーションセグメントと地理的状況が含まれています。
TechnavioのコエンザイムQ10市場は以下のように区分されています。
アプリケーション別
- 健康補助食品
- 医薬品
- 化粧品
地域別の状況
- 北アメリカ
- ヨーロッパ
- アジア
- ROW
本調査では、今後数年間のコエンザイムQ10市場の成長を促進する主な理由の一つとして、健康への関心の高まりを挙げています。また、化粧品への需要の高さとオンライン販売の成長が、市場の大きな需要につながるとしています。
Technavio社は、複数のソースからのデータを調査、合成、主要パラメータの分析によってまとめることで、市場の詳細なイメージを提示しています。当レポートでは、コエンザイムQ10市場について、以下の項目を取り上げています。
- コエンザイムQ10の市場サイジング
- コエンザイムQ10市場の予測
- コエンザイムQ10市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としており、これに沿って本レポートでは、コエンザイムQ10市場の主要ベンダーである、株式会社カネカ、キッコーマン株式会社、キリンホールディングス株式会社、株式会社エヌ・ティ・ティ・ドコモなどの詳細な分析を行っています。本レポートでは、コエンザイムQ10市場の主要ベンダーである株式会社カネカ、キッコーマン株式会社、キリンホールディングス株式会社、Koninklijke DSM NV、Lesaffre and Cie、日清製粉グループ株式会社、大塚ホールディングス株式会社、Pharma Nord Inc.Ltd.、Pharma Nord Inc.、PharmaEssentia Corp.、Zhejiang Medicine Co.Ltd.などがあります。また、コエンザイムQ10の市場分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するためのものです。
本調査は、業界の主要参加者からの情報を含む、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/coenzyme-q10-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的および量的調査を用いた詳細なベンダー選択方法と分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Dietary supplements - Market size and forecast 2020-2025
o Pharmaceuticals - Market size and forecast 2020-2025
o Cosmetics - Market size and forecast 2020-2025
o Market opportunity by Application
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Kaneka Corp.
o Kikkoman Corp.
o Kirin Holdings Co. Ltd.
o Koninklijke DSM NV
o Lesaffre and Cie
o Nisshin Seifun Group Inc.
o Otsuka Holdings Co. Ltd.
o Pharma Nord Inc.
o PharmaEssentia Corp.
o Zhejiang Medicine Co. Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Application - Market share 2020-2025 (%)
• 22: Comparison by Application
• 23: Dietary supplements - Market size and forecast 2020-2025 ($ million)
• 24: Dietary supplements - Year-over-year growth 2020-2025 (%)
• 25: Pharmaceuticals - Market size and forecast 2020-2025 ($ million)
• 26: Pharmaceuticals - Year-over-year growth 2020-2025 (%)
• 27: Cosmetics - Market size and forecast 2020-2025 ($ million)
• 28: Cosmetics - Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by Application
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2020-2025 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2020-2025 ($ million)
• 34: North America - Year-over-year growth 2020-2025 (%)
• 35: Europe - Market size and forecast 2020-2025 ($ million)
• 36: Europe - Year-over-year growth 2020-2025 (%)
• 37: Asia - Market size and forecast 2020-2025 ($ million)
• 38: Asia - Year-over-year growth 2020-2025 (%)
• 39: ROW - Market size and forecast 2020-2025 ($ million)
• 40: ROW - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Kaneka Corp. - Overview
• 50: Kaneka Corp. - Business segments
• 51: Kaneka Corp. - Key offerings
• 52: Kaneka Corp. - Key customers
• 53: Kaneka Corp. - Segment focus
• 54: Kikkoman Corp. - Overview
• 55: Kikkoman Corp. - Business segments
• 56: Kikkoman Corp. - Key offerings
• 57: Kikkoman Corp. - Key customers
• 58: Kikkoman Corp. - Segment focus
• 59: Kirin Holdings Co. Ltd. - Overview
• 60: Kirin Holdings Co. Ltd. - Business segments
• 61: Kirin Holdings Co. Ltd. - Key offerings
• 62: Kirin Holdings Co. Ltd. - Key customers
• 63: Kirin Holdings Co. Ltd. - Segment focus
• 64: Koninklijke DSM NV - Overview
• 65: Koninklijke DSM NV - Business segments
• 66: Koninklijke DSM NV - Key offerings
• 67: Koninklijke DSM NV - Key customers
• 68: Koninklijke DSM NV - Segment focus
• 69: Lesaffre and Cie - Overview
• 70: Lesaffre and Cie - Product and service
• 71: Lesaffre and Cie - Key offerings
• 72: Lesaffre and Cie - Key customers
• 73: Lesaffre and Cie - Segment focus
• 74: Nisshin Seifun Group Inc. - Overview
• 75: Nisshin Seifun Group Inc. - Business segments
• 76: Nisshin Seifun Group Inc. - Key offerings
• 77: Nisshin Seifun Group Inc. - Key customers
• 78: Nisshin Seifun Group Inc. - Segment focus
• 79: Otsuka Holdings Co. Ltd. - Overview
• 80: Otsuka Holdings Co. Ltd. - Business segments
• 81: Otsuka Holdings Co. Ltd. - Key offerings
• 82: Otsuka Holdings Co. Ltd. - Key customers
• 83: Otsuka Holdings Co. Ltd. - Segment focus
• 84: Pharma Nord Inc. - Overview
• 85: Pharma Nord Inc. - Product and service
• 86: Pharma Nord Inc. - Key offerings
• 87: Pharma Nord Inc. - Key customers
• 88: Pharma Nord Inc. - Segment focus
• 89: PharmaEssentia Corp. - Overview
• 90: PharmaEssentia Corp. - Business segments
• 91: PharmaEssentia Corp. - Key offerings
• 92: PharmaEssentia Corp. - Key customers
• 93: PharmaEssentia Corp. - Segment focus
• 94: Zhejiang Medicine Co. Ltd. - Overview
• 95: Zhejiang Medicine Co. Ltd. - Product and service
• 96: Zhejiang Medicine Co. Ltd. - Key offerings
• 97: Zhejiang Medicine Co. Ltd. - Key customers
• 98: Zhejiang Medicine Co. Ltd. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

　

ページTOPに戻る


　

Summary

Global Coenzyme Q10 Market 2021-2025
Technavio has been monitoring the coenzyme Q10 market and it is poised to grow by $ 242.36 mn during 2021-2025, progressing at a CAGR of 6.13% during the forecast period. Our report on the coenzyme Q10 market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing disposable incomes, increase in older adult population, and rising focus on healthy dietary habits. In addition, growing disposable incomes is anticipated to boost the growth of the market as well.
The coenzyme Q10 market analysis includes the application segment and geographic landscape.
Technavio's coenzyme Q10 market is segmented as below:
By Application
• Dietary supplements
• Pharmaceuticals
• Cosmetics
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the increase in health concerns as one of the prime reasons driving the coenzyme Q10 market growth during the next few years. Also, high demand for cosmetics and growth in online sales will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on coenzyme Q10 market covers the following areas:
• Coenzyme Q10 market sizing
• Coenzyme Q10 market forecast
• Coenzyme Q10 market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coenzyme Q10 market vendors that include Kaneka Corp., Kikkoman Corp., Kirin Holdings Co. Ltd., Koninklijke DSM NV, Lesaffre and Cie, Nisshin Seifun Group Inc., Otsuka Holdings Co. Ltd., Pharma Nord Inc., PharmaEssentia Corp., and Zhejiang Medicine Co. Ltd. Also, the coenzyme Q10 market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/coenzyme-q10-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Dietary supplements - Market size and forecast 2020-2025
o Pharmaceuticals - Market size and forecast 2020-2025
o Cosmetics - Market size and forecast 2020-2025
o Market opportunity by Application
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Kaneka Corp.
o Kikkoman Corp.
o Kirin Holdings Co. Ltd.
o Koninklijke DSM NV
o Lesaffre and Cie
o Nisshin Seifun Group Inc.
o Otsuka Holdings Co. Ltd.
o Pharma Nord Inc.
o PharmaEssentia Corp.
o Zhejiang Medicine Co. Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Application - Market share 2020-2025 (%)
• 22: Comparison by Application
• 23: Dietary supplements - Market size and forecast 2020-2025 ($ million)
• 24: Dietary supplements - Year-over-year growth 2020-2025 (%)
• 25: Pharmaceuticals - Market size and forecast 2020-2025 ($ million)
• 26: Pharmaceuticals - Year-over-year growth 2020-2025 (%)
• 27: Cosmetics - Market size and forecast 2020-2025 ($ million)
• 28: Cosmetics - Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by Application
• 30: Customer landscape
• 31: Market share By Geographical Landscape 2020-2025 (%)
• 32: Geographic comparison
• 33: North America - Market size and forecast 2020-2025 ($ million)
• 34: North America - Year-over-year growth 2020-2025 (%)
• 35: Europe - Market size and forecast 2020-2025 ($ million)
• 36: Europe - Year-over-year growth 2020-2025 (%)
• 37: Asia - Market size and forecast 2020-2025 ($ million)
• 38: Asia - Year-over-year growth 2020-2025 (%)
• 39: ROW - Market size and forecast 2020-2025 ($ million)
• 40: ROW - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Kaneka Corp. - Overview
• 50: Kaneka Corp. - Business segments
• 51: Kaneka Corp. - Key offerings
• 52: Kaneka Corp. - Key customers
• 53: Kaneka Corp. - Segment focus
• 54: Kikkoman Corp. - Overview
• 55: Kikkoman Corp. - Business segments
• 56: Kikkoman Corp. - Key offerings
• 57: Kikkoman Corp. - Key customers
• 58: Kikkoman Corp. - Segment focus
• 59: Kirin Holdings Co. Ltd. - Overview
• 60: Kirin Holdings Co. Ltd. - Business segments
• 61: Kirin Holdings Co. Ltd. - Key offerings
• 62: Kirin Holdings Co. Ltd. - Key customers
• 63: Kirin Holdings Co. Ltd. - Segment focus
• 64: Koninklijke DSM NV - Overview
• 65: Koninklijke DSM NV - Business segments
• 66: Koninklijke DSM NV - Key offerings
• 67: Koninklijke DSM NV - Key customers
• 68: Koninklijke DSM NV - Segment focus
• 69: Lesaffre and Cie - Overview
• 70: Lesaffre and Cie - Product and service
• 71: Lesaffre and Cie - Key offerings
• 72: Lesaffre and Cie - Key customers
• 73: Lesaffre and Cie - Segment focus
• 74: Nisshin Seifun Group Inc. - Overview
• 75: Nisshin Seifun Group Inc. - Business segments
• 76: Nisshin Seifun Group Inc. - Key offerings
• 77: Nisshin Seifun Group Inc. - Key customers
• 78: Nisshin Seifun Group Inc. - Segment focus
• 79: Otsuka Holdings Co. Ltd. - Overview
• 80: Otsuka Holdings Co. Ltd. - Business segments
• 81: Otsuka Holdings Co. Ltd. - Key offerings
• 82: Otsuka Holdings Co. Ltd. - Key customers
• 83: Otsuka Holdings Co. Ltd. - Segment focus
• 84: Pharma Nord Inc. - Overview
• 85: Pharma Nord Inc. - Product and service
• 86: Pharma Nord Inc. - Key offerings
• 87: Pharma Nord Inc. - Key customers
• 88: Pharma Nord Inc. - Segment focus
• 89: PharmaEssentia Corp. - Overview
• 90: PharmaEssentia Corp. - Business segments
• 91: PharmaEssentia Corp. - Key offerings
• 92: PharmaEssentia Corp. - Key customers
• 93: PharmaEssentia Corp. - Segment focus
• 94: Zhejiang Medicine Co. Ltd. - Overview
• 95: Zhejiang Medicine Co. Ltd. - Product and service
• 96: Zhejiang Medicine Co. Ltd. - Key offerings
• 97: Zhejiang Medicine Co. Ltd. - Key customers
• 98: Zhejiang Medicine Co. Ltd. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の